Dr Nick Adams n.adams5@rgu.ac.uk
Research Fellow B
Newer antidepressant drugs are frequently cited as having reduced side effect profiles to that of their older counterparts. However, recent studies have begun to dispute this claim, citing selective sampling, short clinical trials, and clinical trial environments as influencing reported outcomes. At present, little research on antidepressant side effects draws on RWD (Real-World Data). Despite this, interest in examining RWD samples for antidepressant drug side effects is increasing as of 2020. The reported study asked a random sample of 300+ individuals taking a variety of different antidepressant medications to complete online drug side effect self-report scales with previously high validity. Newer antidepressants belonging to the atypical antidepressant drug class were reported as having only slightly reduced side effects of weight gain compared with older SSRI-class medications. No reduced side effects of increased depression, anxiety, sexual dysfunction (SD), sleepiness, or suicidal ideation (SI) were found for the newer atypical-class medications vs older SSRI-class agents. Medication adherence did not differ significantly between SSRI and atypical classes. No evidence for reduced side effects was found for newer SSRI and atypical antidepressants vs older same-class drugs when comparing six new and old medications drawn from atypical and SSRI classes. However, atypical antidepressants were associated with increased use of adjunct medications to bolster primary treatment.
ADAMS, N.N. 2020. Do newer antidepressant drugs really have reduced side effects? Examining a random "real world" sample of 300+ receivers of medications. IAFOR Journal of psychology and the behavioral sciences [online], 6(1), article number 05, pages 75-100. Available from: https://doi.org/10.22492/ijpbs.6.1.05
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 27, 2020 |
Online Publication Date | Dec 12, 2020 |
Publication Date | Dec 12, 2020 |
Deposit Date | Dec 17, 2020 |
Publicly Available Date | Dec 17, 2020 |
Journal | IAFOR Journal of psychology and the behavioral sciences |
Electronic ISSN | 2187-0675 |
Publisher | IAFOR (International Academic Forum) |
Peer Reviewed | Peer Reviewed |
Volume | 6 |
Issue | 1 |
Article Number | 05 |
Pages | 75-100 |
DOI | https://doi.org/10.22492/ijpbs.6.1.05 |
Keywords | Antidepressant tolerability; Non-clinical studies; Real-world data; Side effects |
Public URL | https://rgu-repository.worktribe.com/output/1014656 |
ADAMS 2020 Do newer antidepressant drugs
(1.1 Mb)
PDF
Copyright Statement
© Author. See publisher's user licence: http://iafor.org/iafor-user-license/
Unveiling "ex-incels": identity dynamics and juxtaposed hegemonic masculinity.
(2024)
Presentation / Conference Contribution
About OpenAIR@RGU
Administrator e-mail: publications@rgu.ac.uk
This application uses the following open-source libraries:
Apache License Version 2.0 (http://www.apache.org/licenses/)
Apache License Version 2.0 (http://www.apache.org/licenses/)
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search